| JYSB2500077 | 度普利尤单抗注射液 | dupilumab | Injection | Biological Products | Supplementary Application | 2025-03-25 | | Sanofi Winthrop Industrie | | | view |
| JYSB2300135 | 度普利尤单抗注射液 | dupilumab | Injection | Biological Products | Supplementary Application | 2023-08-15 | | Sanofi-Aventis Groupe;Sanofi Winthrop Industrie | | | view |
| JXSS2500063 | 度普利尤单抗注射液 | dupilumab | Injection | Biological Products(3.1) | Import Drug Application | 2025-05-21 | | Sanofi (China) Investment Co Ltd;Sanofi Winthrop Industrie | | | view |
| JYSB2400110 | 度普利尤单抗注射液 | dupilumab | Injection | Biological Products | Supplementary Application | 2024-05-17 | | Sanofi Winthrop Industrie | | | view |
| JYSB2200175 | 度普利尤单抗注射液 | dupilumab | Injection | Biological Products | Supplementary Application | 2022-09-09 | | Sanofi-Aventis Groupe;Sanofi Winthrop Industrie | | | view |
| JYSB2500068 | 度普利尤单抗注射液 | dupilumab | Injection | Biological Products | Supplementary Application | 2025-03-19 | | Sanofi Winthrop Industrie | | | view |
| JXSS2300007 | 度普利尤单抗注射液 | dupilumab | Injection | Biological Products(3.1) | Import Drug Application | 2023-01-12 | | Sanofi-Aventis Groupe;Sanofi (China) Investment Co Ltd;Sanofi Winthrop Industrie | | | view |
| JXSS2500056 | 度普利尤单抗注射液 | dupilumab | Injection | Biological Products(3.1) | Import Drug Application | 2025-05-13 | | Sanofi (China) Investment Co Ltd;Sanofi Winthrop Industrie | | | view |
| JYSB2400077 | 度普利尤单抗注射液 | dupilumab | Injection | Biological Products | Supplementary Application | 2024-04-04 | | Sanofi-Aventis Groupe;Sanofi Winthrop Industrie | | | view |
| JXSS2101006 | 度普利尤单抗注射液 | dupilumab | Injection | Biological Products(3.1) | Import Drug Application | 2021-05-10 | | Sanofi-Aventis Groupe;Sanofi (China) Investment Co Ltd;Sanofi Winthrop Industrie | | | view |
| JXSL2400123 | 度普利尤单抗注射液 | dupilumab | Injection | Biological Products(3.1) | Import Drug Application | 2024-07-12 | | Sanofi (China) Investment Co Ltd;Sanofi Winthrop Industrie | | | view |
| JXSL2200187 | 度普利尤单抗注射液 | dupilumab | Injection | Biological Products(3.1) | Import Drug Application | 2022-10-27 | | Sanofi-Aventis Groupe;Sanofi (China) Investment Co Ltd | | | view |
| JYSB2300134 | 度普利尤单抗注射液 | dupilumab | Injection | Biological Products | Supplementary Application | 2023-08-15 | | Sanofi-Aventis Groupe;Sanofi Winthrop Industrie | | | view |
| JXSS2500060 | 度普利尤单抗注射液 | dupilumab | Injection | Biological Products(3.1) | Import Drug Application | 2025-05-13 | | Sanofi (China) Investment Co Ltd;Sanofi Winthrop Industrie | | | view |
| JYSB2400109 | 度普利尤单抗注射液 | dupilumab | Injection | Biological Products | Supplementary Application | 2024-05-17 | | Sanofi Winthrop Industrie | | | view |
| JYSB2200081 | 度普利尤单抗注射液 | dupilumab | Injection | Biological Products | Supplementary Application | 2022-05-07 | | Sanofi-Aventis Groupe;Sanofi Winthrop Industrie | | | view |
| JXSS2500026 | 度普利尤单抗注射液 | dupilumab | Injection | Biological Products(2.2) | Import Drug Application | 2025-03-15 | | Sanofi (China) Investment Co Ltd;Sanofi Winthrop Industrie | | | view |
| JXSS2300009 | 度普利尤单抗注射液 | dupilumab | Injection | Biological Products(3.1) | Import Drug Application | 2023-01-12 | | Sanofi-Aventis Groupe;Sanofi (China) Investment Co Ltd;Sanofi Winthrop Industrie | | | view |
| JXSS2500059 | 度普利尤单抗注射液 | dupilumab | Injection | Biological Products(3.1) | Import Drug Application | 2025-05-13 | | Sanofi (China) Investment Co Ltd;Sanofi Winthrop Industrie | | | view |
| JYSB2400076 | 度普利尤单抗注射液 | dupilumab | Injection | Biological Products | Supplementary Application | 2024-04-04 | | Sanofi-Aventis Groupe;Sanofi Winthrop Industrie | | | view |
